REMINDER: Our user survey closes on Friday, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksShire Share News (SHP)

  • There is currently no data for SHP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Reuters Business News Schedule at 1500 GMT/11 AM ET

Wed, 25th Apr 2018 16:02

Editor: Steve Orlofsky +1 646 223 6200

Global Picture Desk: +65 6870 3775

Global Graphics Desk: + 65 6870 3595

(All times GMT / ET)

Receive this schedule by email:

http://mediaexpress.reuters.com

TOP STORIES

Comcast confirms $31 bln bid for Sky, sparking battle withFox

LONDON - U.S. media group Comcast submits a $30.7 billionbid for Sky, prompting the European pay TV group to drop itssupport for a lower offer from Rupert Murdoch's Twenty-FirstCentury Fox. (SKY-M&A/COMCAST (UPDATE 4, PIX), moving shortly,by Paul Sandle, 610 words)

Boeing cruises past estimates as margins, sales grow

Boeing Co's profit rose by more than half in the firstquarter, surging past Wall Street estimates, and strong sales ofcommercial jets led it to raise its forecasts for cash flow andearnings after a record 2017. (BOEING-RESULTS/ (UPDATE 3),moved, by Ankit Ajmera, 560 words)

Shire willing to back $64 bln Takeda bid, market signalsdoubts

LONDON/NEW YORK/TOKYO - Rare disease specialist Shire saysit is willing to recommend a sweetened $64 billion offer fromJapan's Takeda Pharmaceutical Co to shareholders, in what wouldbe the biggest acquisition of a drug company this year.(SHIRE-M&A/TAKEDA PHARMA (UPDATE 9, PIX), moved, by Ben Martin,Carl O'Donnell and Sam Nussey, 900 words)

Twitter trounces estimates as growth moves overseas

Twitter Inc reports its second profitable quarter and topsWall Street estimates for revenue and monthly active users, asadvertisers in Asia and other markets outside the United Statesembraced its video ads. (TWITTER-RESULTS/ (UPDATE 2), moved, byDavid Ingram and Munsif Vengattil, 540 words)

General Electric workers, shareholders protest at annualmeeting

IMPERIAL, Pennsylvania - General Electric Co employees andshareholders voice frustration with the company's poorperformance, at the first annual meeting under Chief ExecutiveJohn Flannery, who has presided over a 43 percent decline inGE's stock price since he took over on Aug. 1. (GE-SHAREHOLDERS/(PIX), moving shortly, by Alwyn Scott, 380 words)

MARKETS

Twitter, tech stocks hit as Wall St turns lower

U.S. stocks headed lower with technology bearing the bruntof falls soon after opening as investors worry about rising bondyields, corporate costs and rising trade tensions with China.(USA-STOCKS/ (UPDATE 2), updated throughout the day, 430 words)

+ See also:

- GLOBAL-MARKETS/ (WRAPUP 4, PIX), updated throughout theday, 900 words

Oil hovers near $74 a barrel, U.S. bonds, crude supply casta shadow

LONDON - Oil edges lower from three-year highs reached theprevious day, as rising U.S. fuel inventories and productionweigh on an otherwise bullish market. (GLOBAL-OIL/ (UPDATE 7,PIX), updated throughout the day, 460 words)

INSIGHT

Amazon.com plays catch-up in Brazil as local rivals thrive

SAO PAULO - Amazon may struggle to dominate retail in Brazilas it has elsewhere, according to a dozen executives, analystsand investors interviewed by Reuters. They compare the state ofBrazilian e-commerce to that of the U.S. market 10 years ago —only Amazon's slow rollout here gave rivals a chance to prepare.(AMAZON.COM-BRAZIL/RIVALS (INSIGHT, PIX), moved, by BradHaynes, 1,310 words)

COMPANIES

Viacom beats estimates on Paramount turnaround

Viacom Inc reports bigger-than-expected quarterly profit andrevenue as moves to sell, rather than release, movies helped itsParamount Pictures unit return to profitability.(VIACOM-RESULTS/ (UPDATE 2), moved, by Laharee Chatterjee andJessica Toonkel, 440 words

General Dynamics profit beats expectations; corporate jetsales flag

General Dynamics Corp reports a bigger-than-expectedquarterly profit, with sales of tanks and weapons systemsboosted by greater U.S. defense spending, but the company'soverall sales are hit by flagging sales of its Gulfstreamcorporate jets. (GENERAL DYNAMICS-RESULTS/ (UPDATE 2), moved,320 words)

Hess posts smaller loss on cost cuts, rising oil prices

U.S. oil and gas producer Hess Corp reports its 14thconsecutive quarterly loss, though results beat Wall Street'sexpectations as it cut expenses and benefited from a rise in oilprices. (HESS-RESULTS/ (UPDATE 2), moved, 280 words)

New shingles vaccine shines as currency hits GSK earnings

LONDON - GlaxoSmithKline's new shingles vaccine, Shingrix,exceeded expectations in the first quarter, but the drugmaker'ssales and earnings fell 2 percent, held back by a stronger poundand more pricing pressure in respiratory medicine. (GSK-RESULTS/(UPDATE 2), moved, by Ben Hirschler, 500 words)

Credit Suisse delivers best quarter since Thiam's revamp

ZURICH - Credit Suisse reports its best quarter since ChiefExecutive Tidjane Thiam launched a three-year restructuring planfor the bank, Switzerland's second-biggest. (CREDIT SUISSEGP-RESULTS/ (UPDATE 2), moved, by Brenna Hughes Neghaiwi, 510words)

FOCUS-GM banks on Chinese vehicle family to boost Brazilsales

DETROIT/SAO PAULO - General Motors is planning for long-termprofitability in South America built on the back of draconiancost cutting during Brazil's recession and the same low-costvehicles it is developing for Chinese consumers, which are dueto hit dealerships in 2019. (GM-BRAZIL/ (PIX), moved, by NickCarey and Brad Haynes, 820 words)

Austrian court blocks Uber in Vienna - taxi group

ZURICH - A commercial court in Vienna has issued a temporaryinjunction to stop ride-hailing service Uber from operating inVienna, ruling in favor of a taxi company that sued Uber forviolating the city's taxi regulations. (UBER-AUSTRIA/ (PIX),moved, 210 words)

Google overhauls Gmail to lure businesses away fromMicrosoft

Alphabet Inc's Google unveils its first Gmail redesign since2013, capping what the company says is an expensive overhaul twoyears in the making to adopt security and offline functionalityand better resemble Microsoft Outlook. (ALPHABET-GOOGLE/GMAIL,moved, by Paresh Dave, 420 words)

More News
6 Sep 2019 07:54

UPDATE 1-Sumitomo Dainippon Pharma investing $3 bln in Swiss Roivant in overseas push

* Dainippon to buy 10% stake in Roivant and interests in 5 units * Schizophrenia treatment Latuda to lose US exclusivity in 2023 * Japan pharma firms grapple with declining Dainippon

Read more
14 Aug 2019 06:45

UPDATE 1-Germany's Stada 'very selective' on acquisitions - CEO Goldschmidt

FRANKFURT, Aug 14 (Reuters) - German generic drugmaker Stada will be careful about buying businesses and companies outright, and for now will focus mainly on striking production and development we

Read more
17 Jul 2019 17:55

Takeda kicks off sale of Western European drugs - sources

By Arno Schuetze and Pamela Barbaglia FRANKFURT/LONDON, July 17 (Reuters) - Japan's Takeda Pharmaceutical Co has reached out to prospective bidders for a portfolio of drugs for sale in

Read more
16 May 2019 18:35

Japan's Takeda expects binding offers for Latam business by end of May -sources

By Tatiana Bautzer SAO PAULO, May 16 (Reuters) - Japan's Takeda Pharmaceutical Co expects to receive binding offers for its Latin American business by the end of May, three sources of a

Read more
15 May 2019 08:05

Nikkei snaps 7-day losing streak helped by China's stimulus hopes

* Gains may be short-lived - analyst * Takeda Pharma, Nissan sink after earnings shock * Mitsubishi Estate jumps on share buyback, governance reform By Hideyuki Sano and Ayai

Read more
15 May 2019 04:04

Nikkei hobbled by trade worries, disappointing earnings

* Nikkei down slightly after 7 losing sessions * Uncertainties over U.S.-China standoff keep investors on edge * Takeda Pharma, Nissan sink after earnings shock * Mitsubishi -

Read more
14 May 2019 07:56

UPDATE 1-Japan's Takeda forecasts 193 bln yen annual operating loss on Shire deal

* 193 bln Y op loss forecast this yr vs 227.5 bln profit view of analysts * Shire acquisition made Takeda one of the world's most indebted drugmakers (Adds details of results, May 14 -

Read more
14 May 2019 07:39

Japan's Takeda expects annual loss on Shire deal

TOKYO, May 14 (Reuters) - Takeda Pharmaceutical Co forecast on Tuesday it would have an operating loss in the current financial year, as it books costs associated with the multibillion-dollar an a

Read more
9 May 2019 00:38

UPDATE 1-Novartis buys Takeda's dry eye drug for $3.4 bln

May 8 (Reuters) - Swiss drugmaker Novartis AG said on Wednesday it agreed to acquire Takeda Pharmaceutical Company Ltd's dry eye drug Xiidra for $3.4 billion, as well as potential milestone of

Read more
1 Feb 2019 06:07

Japan's Takeda posts 28 pct rise in Q3 operating profit

TOKYO, Feb 1 (Reuters) - Takeda Pharmaceutical Co Ltd on Friday posted a 27.9 percent rise in third-quarter operating profit, supported by strong sales of its drugs for bowel disease and multiple

Read more
22 Jan 2019 02:46

Nikkei dips as global growth concerns sap risk appetite

* IMF cuts global growth forecasts * Companies with big China exposure fall * Totech soars after raising earnings forecast By Ayai Tomisawa TOKYO, Jan 22 (Reuters) - in

Read more
8 Jan 2019 13:54

MARKET ANALYSIS: Optimism About Trade Talks May Generate Continued Buying Interest

WASHINGTON (Alliance News) - The major US index futures are pointing to a higher opening on Tuesday, with stocks likely to extend the strong upward move seen over the two previous about trade the

Read more
8 Jan 2019 08:58

Asian Shares Mixed Despite US-China Trade Deal Optimism

CANBERA (Alliance News) - Asian stocks ended mixed on Tuesday despite optimism over US-China trade talks as US officials held a second day of trade talks with Chinese counterparts in second day of

Read more
8 Jan 2019 07:39

Takeda takes control of Shire

(Sharecast News) - Takeda Pharmaceutical has taken full control of Shire after the legal particulars of its cash and share offer were completed.

Read more
7 Jan 2019 04:29

Takeda unlikely to sell OTC drug business -CEO

(Adds quote, other details) TOKYO, Jan 7 (Reuters) - Takeda Pharmaceutical is unlikely to sell its over-the-counter (OTC) drug business even amid pressure to improve its finances as it a a

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.